Ablaze Pharmaceuticals

A bevy of big venture capital financings have been announced since Labor Day, the official end of summer in the US, led by a $300m series C round for Acelyrin, Inc. The boom in VC mega-deals is rema

As the major introductory fundraise for start-ups, Series A financings represent the first-time companies raise substantial equity from venture investors. Prior to the Series A, new firms may raise fu

Jonathan Behr, a US partner at the Dementia Discovery Fund (DDF), sees the increase during the past few years in early-stage investments in neurodegeneration-focused biopharmaceutical companies having